Eli Lilly shows up to have energy in sales of GLP-1 medicines, however expert Søren Løntoft Hansen from Sydbank likewise has actually elevated his assumptions for Danish Novo Nordisk based upon the United States numbers.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/analyst-eli-lillys-growth-worries-novo-investors-but-may-be-a-positive-indicator-for-next-weeks-financial-results/